Acta Neuropathologica

, Volume 127, Issue 1, pp 71–90 | Cite as

Human alcohol-related neuropathology

  • Suzanne M. de la Monte
  • Jillian J. Kril


Alcohol-related diseases of the nervous system are caused by excessive exposures to alcohol, with or without co-existing nutritional or vitamin deficiencies. Toxic and metabolic effects of alcohol (ethanol) vary with brain region, age/developmental stage, dose, and duration of exposures. In the mature brain, heavy chronic or binge alcohol exposures can cause severe debilitating diseases of the central and peripheral nervous systems, and skeletal muscle. Most commonly, long-standing heavy alcohol abuse leads to disproportionate loss of cerebral white matter and impairments in executive function. The cerebellum (especially the vermis), cortical-limbic circuits, skeletal muscle, and peripheral nerves are also important targets of chronic alcohol-related metabolic injury and degeneration. Although all cell types within the nervous system are vulnerable to the toxic, metabolic, and degenerative effects of alcohol, astrocytes, oligodendrocytes, and synaptic terminals are major targets, accounting for the white matter atrophy, neural inflammation and toxicity, and impairments in synaptogenesis. Besides chronic degenerative neuropathology, alcoholics are predisposed to develop severe potentially life-threatening acute or subacute symmetrical hemorrhagic injury in the diencephalon and brainstem due to thiamine deficiency, which exerts toxic/metabolic effects on glia, myelin, and the microvasculature. Alcohol also has devastating neurotoxic and teratogenic effects on the developing brain in association with fetal alcohol spectrum disorder/fetal alcohol syndrome. Alcohol impairs function of neurons and glia, disrupting a broad array of functions including neuronal survival, cell migration, and glial cell (astrocytes and oligodendrocytes) differentiation. Further progress is needed to better understand the pathophysiology of this exposure-related constellation of nervous system diseases and better correlate the underlying pathology with in vivo imaging and biochemical lesions.


White Matter Hepatic Encephalopathy Fetal Alcohol Spectrum Disorder Fetal Alcohol Spectrum Disorder Thiamine Deficiency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Supported by AA-11431, AA-12908 and AA-12725 from the National Institutes of Health.


  1. 1.
    Adachi J, Asano M, Ueno Y et al (2003) Alcoholic muscle disease and biomembrane perturbations (review). J Nutr Biochem 14(11):616–625PubMedGoogle Scholar
  2. 2.
    Aggunlu L, Oner Y, Kocer B, Akpek S (2008) The value of diffusion-weighted imaging in the diagnosis of Marchiafava–Bignami disease: apropos of a case. J Neuroimaging: Off J Am Soc Neuroimaging 18(2):188–190. doi: 10.1111/j.1552-6569.2007.00202.x Google Scholar
  3. 3.
    Akai J, Akai K (1989) Neuropathological study of the nucleus basalis of meynert in alcoholic dementia. Arukoru kenkyu to yakubutsu izon = Jpn J Alcohol Stud Drug Depend 24(2):80–88Google Scholar
  4. 4.
    Albrecht J, Sidoryk-Wegrzynowicz M, Zielinska M, Aschner M (2010) Roles of glutamine in neurotransmission. Neuron Glia Biol 6(4):263–276. doi: 10.1017/S1740925X11000093 PubMedGoogle Scholar
  5. 5.
    Altamirano J, Bataller R (2011) Alcoholic liver disease: pathogenesis and new targets for therapy. Nat Rev Gastroenterol Hepatol 8(9):491–501. doi: 10.1038/nrgastro.2011.134 PubMedGoogle Scholar
  6. 6.
    Ammendola A, Tata MR, Aurilio C et al (2001) Peripheral neuropathy in chronic alcoholism: a retrospective cross-sectional study in 76 subjects. Alcohol 36(3):271–275Google Scholar
  7. 7.
    An JY, Park SK, Han SR, Song IU (2010) Central pontine and extrapontine myelinolysis that developed during alcohol withdrawal, without hyponatremia, in a chronic alcoholic. Intern Med 49(6):615–618PubMedGoogle Scholar
  8. 8.
    Andersen BB (2004) Reduction of Purkinje cell volume in cerebellum of alcoholics. Brain Res 1007(1–2):10–18. doi: 10.1016/j.brainres.2004.01.058 PubMedGoogle Scholar
  9. 9.
    Antar R, Wong P, Ghali P (2012) A meta-analysis of nutritional supplementation for management of hospitalized alcoholic hepatitis. Can J Gastroenterol = J Can de Gastroenterologie 26(7):463–467Google Scholar
  10. 10.
    Archibald SL, Fennema-Notestine C, Gamst A, Riley EP, Mattson SN, Jernigan TL (2001) Brain dysmorphology in individuals with severe prenatal alcohol exposure. Dev Med Child Neurol 43(3):148–154PubMedGoogle Scholar
  11. 11.
    Baker KG, Harding AJ, Halliday GM, Kril JJ, Harper CG (1999) Neuronal loss in functional zones of the cerebellum of chronic alcoholics with and without Wernicke’s encephalopathy. Neuroscience 91(2):429–438PubMedGoogle Scholar
  12. 12.
    Baron R, Heuser K, Marioth G (1989) Marchiafava–Bignami disease with recovery diagnosed by CT and MRI: demyelination affects several CNS structures. J Neurol 236(6):364–366PubMedGoogle Scholar
  13. 13.
    Bhatara VS, Lovrein F, Kirkeby J, Swayze V 2nd, Unruh E, Johnson V (2002) Brain function in fetal alcohol syndrome assessed by single photon emission computed tomography. S D J Med 55(2):59–62PubMedGoogle Scholar
  14. 14.
    Bjorkquist OA, Fryer SL, Reiss AL, Mattson SN, Riley EP (2010) Cingulate gyrus morphology in children and adolescents with fetal alcohol spectrum disorders. Psychiatry Res 181(2):101–107. doi: 10.1016/j.pscychresns.2009.10.004 PubMedPubMedCentralGoogle Scholar
  15. 15.
    Blaha M, Aaslid R, Douville CM, Correra R, Newell DW (2003) Cerebral blood flow and dynamic cerebral autoregulation during ethanol intoxication and hypercapnia. J Clin Neurosci: Off J Neurosurg Soc Aust 10(2):195–198Google Scholar
  16. 16.
    Blanco-Munez O, Suarez-Gauthier A, Martin-Garcia H, Diaz-Konrad V, San Antonio-Roman V, Cabello A (2006) Unusual cortical compromise in a case of Wernicke’s encephalopathy. Revis Neurol 42(10):596–599Google Scholar
  17. 17.
    Bouchery EE, Harwood HJ, Sacks JJ, Simon CJ, Brewer RD (2011) Economic costs of excessive alcohol consumption in the US, 2006. Am J Prev Med 41(5):516–524. doi: 10.1016/j.amepre.2011.06.045 PubMedGoogle Scholar
  18. 18.
    Bourrat C, Tommasi M, Bochu M, Kopp N, Malsch S (1984) X-ray scanning in Marchiafava–Bignami disease. Rev Neurol 140(6–7):426–431PubMedGoogle Scholar
  19. 19.
    Buhler M, Mann K (2011) Alcohol and the human brain: a systematic review of different neuroimaging methods. Alcohol Clin Exp Res 35(10):1771–1793. doi: 10.1111/j.1530-0277.2011.01540.x PubMedGoogle Scholar
  20. 20.
    Butterworth RF (1993) Portal-systemic encephalopathy: a disorder of neuron-astrocytic metabolic trafficking. Dev Neurosci 15(3–5):313–319PubMedGoogle Scholar
  21. 21.
    Butterworth RF (1994) Cerebral dysfunction in chronic alcoholism: role of alcoholic liver disease. Alcohol Suppl 2:259–265Google Scholar
  22. 22.
    Butterworth RF (2003) Role of circulating neurotoxins in the pathogenesis of hepatic encephalopathy: potential for improvement following their removal by liver assist devices. Liver Int: Off J Int Assoc Study Liver 23(Suppl 3):5–9Google Scholar
  23. 23.
    Butterworth RF, Giguere JF, Michaud J, Lavoie J, Layrargues GP (1987) Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 6(1–2):1–12PubMedGoogle Scholar
  24. 24.
    Cardenas VA, Durazzo TC, Gazdzinski S, Mon A, Studholme C, Meyerhoff DJ (2011) Brain morphology at entry into treatment for alcohol dependence is related to relapse propensity. Biol Psychiatry 70(6):561–567. doi: 10.1016/j.biopsych.2011.04.003 PubMedPubMedCentralGoogle Scholar
  25. 25.
    Cavanagh JB (1993) Selective vulnerability in acute energy deprivation syndromes. Neuropathol Appl Neurobiol 19(6):461–470PubMedGoogle Scholar
  26. 26.
    Charness ME (1993) Brain lesions in alcoholics. Alcohol Clin Exp Res 17(1):2–11PubMedGoogle Scholar
  27. 27.
    Chavarria L, Alonso J, Garcia-Martinez R et al (2013) Brain magnetic resonance spectroscopy in episodic hepatic encephalopathy. J Cereb Blood Flow Metab: Off J Int Soc Cereb Blood Flow Metab 33(2):272–277. doi: 10.1038/jcbfm.2012.173 Google Scholar
  28. 28.
    Chen CH, Walker J, Momenan R, Rawlings R, Heilig M, Hommer DW (2012) Relationship between liver function and brain shrinkage in patients with alcohol dependence. Alcohol Clin Exp Res 36(4):625–632. doi: 10.1111/j.1530-0277.2011.01662.x PubMedPubMedCentralGoogle Scholar
  29. 29.
    Clements RH, Katasani VG, Palepu R et al (2006) Incidence of vitamin deficiency after laparoscopic Roux-en-Y gastric bypass in a university hospital setting. Am Surg 72(12):1196–1202 (discussion 1203–1194)PubMedGoogle Scholar
  30. 30.
    Cohen AC, Tong M, Wands JR, de la Monte SM (2007) Insulin and insulin-like growth factor resistance with neurodegeneration in an adult chronic ethanol exposure model. Alcohol Clin Exp Res 31(9):1558–1573. doi: 10.1111/j.1530-0277.2007.00450.x PubMedGoogle Scholar
  31. 31.
    Collins GH, Converse WK (1970) Cerebellar degeneration in thiamine-deficient rats. Am J Pathol 58(2):219–233PubMedGoogle Scholar
  32. 32.
    Conn HO, Rossle M, Levy L, Glocker FX (2006) Portosystemic myelopathy: spastic paraparesis after portosystemic shunting. Scand J Gastroenterol 41(5):619–625. doi: 10.1080/00365520500318932 PubMedGoogle Scholar
  33. 33.
    de la Monte SM (1988) Disproportionate atrophy of cerebral white matter in chronic alcoholics. Arch Neurol 45(9):990–992PubMedGoogle Scholar
  34. 34.
    de la Monte SM, Longato L, Tong M, DeNucci S, Wands JR (2009) The liver-brain axis of alcohol-mediated neurodegeneration: role of toxic lipids. Int J Environ Res Public Health 6(7):2055–2075. doi: 10.3390/ijerph6072055 PubMedGoogle Scholar
  35. 35.
    Del Villar Negro A, Merino Angulo J, Rivera-Pomar JM (1984) Skeletal muscle changes in chronic alcoholic patients. A conventional, histochemical, ultrastructural and morphometric study. Acta Neurol Scand 70(3):185–196PubMedGoogle Scholar
  36. 36.
    del Villar Negro A, Merino Angulo J, Rivera Pomar JM, Aguirre Errasti C (1982) Tubular aggregates in skeletal muscle of chronic alcoholic patients. Acta Neuropathol 56(4):250–254PubMedGoogle Scholar
  37. 37.
    Disabilities AAoPCoSAaCoCW (2000) Fetal alcohol syndrome and alcohol-related neurodevelopmental disorders. Pediatrics 106(2 Pt 1):358–361Google Scholar
  38. 38.
    Droblenkov AV (2011) Morphological signs of ethanol poisoning, alcohol abstinence and chronic alcoholic intoxication in the mesocorticolimbic dopaminergic system. Sud Med Ekspert 54(5):11–17PubMedGoogle Scholar
  39. 39.
    Duane P, Peters TJ (1988) Nutritional status in alcoholics with and without chronic skeletal muscle myopathy. Alcohol 23(4):271–277Google Scholar
  40. 40.
    Duddempudi AT (2012) Immunology in alcoholic liver disease. Clin Liver Dis 16(4):687–698. doi: 10.1016/j.cld.2012.08.003 PubMedGoogle Scholar
  41. 41.
    Enoch MA (2012) The influence of gene-environment interactions on the development of alcoholism and drug dependence. Curr Psychiatry Rep 14(2):150–158. doi: 10.1007/s11920-011-0252-9 PubMedPubMedCentralGoogle Scholar
  42. 42.
    Estruch R, Sacanella E, Fernandez-Sola J, Nicolas JM, Rubin E, Urbano-Marquez A (1998) Natural history of alcoholic myopathy: a 5-year study. Alcohol Clin Exp Res 22(9):2023–2028PubMedGoogle Scholar
  43. 43.
    Fernandez-Sola J, Sacanella E, Estruch R, Nicolas JM, Grau JM, Urbano-Marquez A (1995) Significance of type II fiber atrophy in chronic alcoholic myopathy. J Neurol Sci 130(1):69–76PubMedGoogle Scholar
  44. 44.
    Finlayson M (1982) Observations on the pathogenesis of hepatocerebral degeneration in cirrhosis. Bol Estud Med Biol 32(1–2):3–11PubMedGoogle Scholar
  45. 45.
    Fortier CB, Leritz EC, Salat DH et al (2011) Reduced cortical thickness in abstinent alcoholics and association with alcoholic behavior. Alcohol Clin Exp Res 35(12):2193–2201. doi: 10.1111/j.1530-0277.2011.01576.x PubMedPubMedCentralGoogle Scholar
  46. 46.
    Freund G, Ballinger WE (1991) Loss of synaptic receptors can precede morphologic changes induced by alcoholism. Alcohol Suppl 1:385–391Google Scholar
  47. 47.
    Freund G, Ballinger WE Jr (1988) Loss of cholinergic muscarinic receptors in the frontal cortex of alcohol abusers. Alcohol Clin Exp Res 12(5):630–638PubMedGoogle Scholar
  48. 48.
    Gao B, Bataller R (2011) Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141(5):1572–1585. doi: 10.1053/j.gastro.2011.09.002 PubMedPubMedCentralGoogle Scholar
  49. 49.
    Gazdzinski S, Durazzo TC, Mon A, Yeh PH, Meyerhoff DJ (2010) Cerebral white matter recovery in abstinent alcoholics—a multimodality magnetic resonance study. Brain: J Neurol 133(Pt 4):1043–1053. doi: 10.1093/brain/awp343 Google Scholar
  50. 50.
    Gocht A, Lohler J (1990) Changes in glial cell markers in recent and old demyelinated lesions in central pontine myelinolysis. Acta Neuropathol 80(1):46–58PubMedGoogle Scholar
  51. 51.
    Grewal P, Viswanathen VA (2012) Liver cancer and alcohol. Clin Liver Dis 16(4):839–850. doi: 10.1016/j.cld.2012.08.011 PubMedGoogle Scholar
  52. 52.
    Guerri C, Bazinet A, Riley EP (2009) Foetal alcohol spectrum disorders and alterations in brain and behaviour. Alcohol 44(2):108–114. doi: 10.1093/alcalc/agn105 Google Scholar
  53. 53.
    Guevara M, Baccaro ME, Gomez-Anson B et al (2011) Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy. J Hepatol 55(3):564–573. doi: 10.1016/j.jhep.2010.12.008 PubMedGoogle Scholar
  54. 54.
    Gui QP, Zhao WQ, Wang LN (2006) Wernicke’s encephalopathy in nonalcoholic patients: clinical and pathologic features of three cases and literature reviewed. Neuropathol: Off J Jpn Soc Neuropathol 26(3):231–235Google Scholar
  55. 55.
    Guo YP, McLeod JG (1990) Pathological changes in the vagus nerves in chronic alcoholism. Zhonghua shen jing jing shen ke za zhi = Chin J NeurolPsychiatry 23(4):234–236 (p 255)Google Scholar
  56. 56.
    Harada T, Ishizaki F, Horie N et al (2011) Alcohol-induced persistent mild cognitive impairment with successful withdrawal from alcohol dependence—a case report. Hiroshima J Med Sci 60(1):11–13PubMedGoogle Scholar
  57. 57.
    Harding AJ, Wong A, Svoboda M, Kril JJ, Halliday GM (1997) Chronic alcohol consumption does not cause hippocampal neuron loss in humans. Hippocampus 7(1):78–87. doi: 10.1002/(SICI)1098-1063(1997)7:1<78:AID-HIPO8>3.0.CO;2-3 PubMedGoogle Scholar
  58. 58.
    Harper C (2007) The neurotoxicity of alcohol. Hum Exp Toxicol 26(3):251–257. doi: 10.1177/0960327107070499 PubMedGoogle Scholar
  59. 59.
    Harper C, Fornes P, Duyckaerts C, Lecomte D, Hauw JJ (1995) An international perspective on the prevalence of the Wernicke–Korsakoff syndrome. Metab Brain Dis 10(1):17–24PubMedGoogle Scholar
  60. 60.
    Harper CG, Sheedy DL, Lara AI, Garrick TM, Hilton JM, Raisanen J (1998) Prevalence of Wernicke–Korsakoff syndrome in Australia: has thiamine fortification made a difference? Med J Aust 168(11):542–545PubMedPubMedCentralGoogle Scholar
  61. 61.
    Hauw JJ, De Baecque C, Hausser-Hauw C, Serdaru M (1988) Chromatolysis in alcoholic encephalopathies. Pellagra-like changes in 22 cases. Brain J Neurol 111(Pt 4):843–857Google Scholar
  62. 62.
    Hazell AS, Butterworth RF (1999) Hepatic encephalopathy: an update of pathophysiologic mechanisms. Proc Soc Exp Biol Med 222(2):99–112PubMedGoogle Scholar
  63. 63.
    He X, Sullivan EV, Stankovic RK, Harper CG, Pfefferbaum A (2007) Interaction of thiamine deficiency and voluntary alcohol consumption disrupts rat corpus callosum ultrastructure. Neuropsychopharmacol: Off Pub Am Coll Neuropsychopharmacol 32(10):2207–2216. doi: 10.1038/sj.npp.1301332 Google Scholar
  64. 64.
    Heepe P, Nemeth L, Brune F, Grant JW, Kleihues P (1988) Marchiafava–Bignami disease. A correlative computed tomography and morphological study. Eur Arch Psychiatry Neurol Sci 237(2):74–79PubMedGoogle Scholar
  65. 65.
    Iannelli A, Addeo P, Novellas S, Gugenheim J (2010) Wernicke’s encephalopathy after laparoscopic Roux-en-Y gastric bypass: a misdiagnosed complication. Obes Surg 20(11):1594–1596. doi: 10.1007/s11695-010-0116-0 PubMedGoogle Scholar
  66. 66.
    Ibrahim NB (1981) Central pontine myelinolysis. Postgrad Med J 57(665):178–180PubMedGoogle Scholar
  67. 67.
    Isaksson A, Walther L, Hansson T, Andersson A, Alling C (2011) Phosphatidylethanol in blood (B-PEth): a marker for alcohol use and abuse. Drug Test Anal 3(4):195–200. doi: 10.1002/dta.278 PubMedGoogle Scholar
  68. 68.
    Iwabuchi K, Yagishita S, Itoh Y, Amano N, Saitoh A (1990) An autopsied case of alcoholic cerebellar degeneration with spastic paraplegia and neuropathy. No to shinkei = Brain Nerve 42(5):489–496PubMedGoogle Scholar
  69. 69.
    Jepsen P, Ott P, Andersen PK, Vilstrup H (2012) The clinical course of alcoholic cirrhosis: effects of hepatic metabolic capacity, alcohol consumption, and hyponatremia—a historical cohort study. BMC Res Notes 5:509. doi: 10.1186/1756-0500-5-509 PubMedPubMedCentralGoogle Scholar
  70. 70.
    Jochum T, Reinhard M, Boettger MK, Piater M, Bar KJ (2010) Impaired cerebral autoregulation during acute alcohol withdrawal. Drug Alcohol Depend 110(3):240–246. doi: 10.1016/j.drugalcdep.2010.03.007 PubMedGoogle Scholar
  71. 71.
    Johnsen-Soriano S, Bosch-Morell F, Miranda M et al (2007) Ebselen prevents chronic alcohol-induced rat hippocampal stress and functional impairment. Alcohol Clin Exp Res 31(3):486–492. doi: 10.1111/j.1530-0277.2006.00329.x PubMedGoogle Scholar
  72. 72.
    Jung YC, Chanraud S, Sullivan EV (2012) Neuroimaging of Wernicke’s encephalopathy and Korsakoff’s syndrome. Neuropsychol Rev 22(2):170–180. doi: 10.1007/s11065-012-9203-4 PubMedGoogle Scholar
  73. 73.
    Kapogiannis D, Kisser J, Davatzikos C, Ferrucci L, Metter J, Resnick SM (2012) Alcohol consumption and premotor corpus callosum in older adults. Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol 22(10):704–710. doi: 10.1016/j.euroneuro.2012.02.003 Google Scholar
  74. 74.
    Karhunen PJ, Erkinjuntti T, Laippala P (1994) Moderate alcohol consumption and loss of cerebellar Purkinje cells. BMJ 308(6945):1663–1667PubMedGoogle Scholar
  75. 75.
    Kishimoto Y, Ikeda K, Murata K, Kawabe K, Hirayama T, Iwasaki Y (2012) Rapid development of central pontine myelinolysis after recovery from Wernicke encephalopathy: a non-alcoholic case without hyponatremia. Intern Med 51(12):1599–1603PubMedGoogle Scholar
  76. 76.
    Knill-Jones RP, Goodwill CJ, Dayan AD, Williams R (1972) Peripheral neuropathy in chronic liver disease: clinical, electrodiagnostic, and nerve biopsy findings. J Neurol Neurosurg Psychiatry 35(1):22–30PubMedGoogle Scholar
  77. 77.
    Koike H, Iijima M, Sugiura M et al (2003) Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy. Ann Neurol 54(1):19–29. doi: 10.1002/ana.10550 PubMedGoogle Scholar
  78. 78.
    Konrad A, Vucurevic G, Lorscheider M et al (2012) Broad disruption of brain white matter microstructure and relationship with neuropsychological performance in male patients with severe alcohol dependence. Alcohol 47(2):118–126. doi: 10.1093/alcalc/agr157 Google Scholar
  79. 79.
    Koo JE, Lim YS, Myung SJ et al (2008) Hepatic myelopathy as a presenting neurological complication in patients with cirrhosis and spontaneous splenorenal shunt. Korean J Hepatol 14(1):89–96. doi: 10.3350/kjhep.2008.14.1.89 PubMedGoogle Scholar
  80. 80.
    Kosaka K, Aoki M, Kawasaki N, Adachi Y, Konuma I, Iizuka R (1984) A non-alcoholic Japanese patient with Wernicke’s encephalopathy and Marchiafava–Bignami disease. Clin Neuropathol 3(6):231–236PubMedGoogle Scholar
  81. 81.
    Kril JJ, Butterworth RF (1997) Diencephalic and cerebellar pathology in alcoholic and nonalcoholic patients with end-stage liver disease. Hepatology 26(4):837–841. doi: 10.1002/hep.510260405 PubMedGoogle Scholar
  82. 82.
    Kril JJ, Halliday GM, Svoboda MD, Cartwright H (1997) The cerebral cortex is damaged in chronic alcoholics. Neuroscience 79(4):983–998PubMedGoogle Scholar
  83. 83.
    Kurup RK, Kurup PA (2003) Hypothalamic digoxin and hemispheric chemical dominance: relation to alcoholic addiction, alcoholic cirrhosis, and acquired hepatocerebral degeneration. Int J Neurosci 113(8):1105–1125. doi: 10.1080/00207450390212023 PubMedGoogle Scholar
  84. 84.
    Lefer LG, Vogel FS (1972) Encephalomyelopathy with hepatic cirrhosis following portosystemic venous shunts. Arch Pathol 93(2):91–97PubMedGoogle Scholar
  85. 85.
    Leong AS (1979) Marchiafava–Bignami disease in a non-alcoholic Indian male. Pathology 11(2):241–249PubMedGoogle Scholar
  86. 86.
    Lindboe CF, Loberg EM (1988) The frequency of brain lesions in alcoholics. Comparison between the 5-year periods 1975–1979 and 1983–1987. J Neurol Sci 88(1–3):107–113PubMedGoogle Scholar
  87. 87.
    Liu IC, Chiu CH, Chen CJ, Kuo LW, Lo YC, Tseng WY (2010) The microstructural integrity of the corpus callosum and associated impulsivity in alcohol dependence: a tractography-based segmentation study using diffusion spectrum imaging. Psychiatry Res 184(2):128–134. doi: 10.1016/j.pscychresns.2010.07.002 PubMedGoogle Scholar
  88. 88.
    Longato L, Ripp K, Setshedi M et al (2012) Insulin resistance, ceramide accumulation, and endoplasmic reticulum stress in human chronic alcohol-related liver disease. Oxid Med Cell Long 2012:479348. doi: 10.1155/2012/479348 Google Scholar
  89. 89.
    Lough ME (2012) Wernicke’s encephalopathy: expanding the diagnostic toolbox. Neuropsychol Rev 22(2):181–194. doi: 10.1007/s11065-012-9200-7 PubMedGoogle Scholar
  90. 90.
    Louis G, Megarbane B, Lavoue S et al (2012) Long-term outcome of patients hospitalized in intensive care units with central or extrapontine myelinolysis. Crit Care Med 40(3):970–972. doi: 10.1097/CCM.0b013e318236f152 PubMedGoogle Scholar
  91. 91.
    Low PA, Walsh JC, Huang CY, McLeod JG (1975) The sympathetic nervous system in alcoholic neuropathy. A clinical and pathological study. Brain: J Neurol 98(3):357–364Google Scholar
  92. 92.
    Lukoyanov NV, Pereira PA, Paula-Barbosa MM, Cadete-Leite A (2003) Nerve growth factor improves spatial learning and restores hippocampal cholinergic fibers in rats withdrawn from chronic treatment with ethanol. Exp Brain Res Exp Hirnforschung Exp Cereb 148(1):88–94. doi: 10.1007/s00221-002-1290-7 Google Scholar
  93. 93.
    Martin FC, Slavin G, Levi AJ, Peters TJ (1984) Investigation of the organelle pathology of skeletal muscle in chronic alcoholism. J Clin Pathol 37(4):448–454PubMedGoogle Scholar
  94. 94.
    Matsui T, Sakurai H, Toyama T, Yoshimura A, Matsushita S, Higuchi S (2012) Clinical application of neuroimaging to alcohol-related dementia. Nihon Arukoru Yakubutsu Igakkai zasshi = Jpn J Alcohol Stud Drug Depend 47(3):125–134Google Scholar
  95. 95.
    Matthews PM, Marchington DR, Squier M, Land J, Brown RM, Brown GK (1993) Molecular genetic characterization of an X-linked form of Leigh’s syndrome. Ann Neurol 33(6):652–655. doi: 10.1002/ana.410330616 PubMedGoogle Scholar
  96. 96.
    Mellion M, Gilchrist JM, de la Monte S (2011) Alcohol-related peripheral neuropathy: nutritional, toxic, or both? Muscle Nerve 43(3):309–316. doi: 10.1002/mus.21946 PubMedGoogle Scholar
  97. 97.
    Mellion ML, Silbermann E, Gilchrist JM, Leggio L, de la Monte SM (2013) Small fiber involvement in alcohol related peripheral neuropathy (ALN). Ann Neurol 74(Suppl 17):S100Google Scholar
  98. 98.
    Mills KR, Ward K, Martin F, Peters TJ (1986) Peripheral neuropathy and myopathy in chronic alcoholism. Alcohol 21(4):357–362Google Scholar
  99. 99.
    Mizuguchi M, Tomonaga M (1989) Acute encephalopathy with symmetrical, widespread, edematous and necrotic lesions–an autopsy case report. No to shinkei = Brain Nerve 41(8):789–794PubMedGoogle Scholar
  100. 100.
    Nardelli A, Lebel C, Rasmussen C, Andrew G, Beaulieu C (2011) Extensive deep gray matter volume reductions in children and adolescents with fetal alcohol spectrum disorders. Alcohol Clin Exp Res 35(8):1404–1417. doi: 10.1111/j.1530-0277.2011.01476.x PubMedGoogle Scholar
  101. 101.
    Nazarov B, Jeannin S, Mejdoubi M, Signate A, Smadja D (2011) Teaching neuroimages: bilateral anterior thalami and fornix macrohemorrhage in Wernicke–Korsakoff syndrome. Neurology 77(22):e129. doi: 10.1212/WNL.0b013e31823a0ca5 PubMedGoogle Scholar
  102. 102.
    Niccols A (2007) Fetal alcohol syndrome and the developing socio-emotional brain. Brain Cogn 65(1):135–142. doi: 10.1016/j.bandc.2007.02.009 PubMedGoogle Scholar
  103. 103.
    Nicolas JM, Garcia G, Fatjo F et al (2003) Influence of nutritional status on alcoholic myopathy. Am J Clin Nutr 78(2):326–333PubMedGoogle Scholar
  104. 104.
    Nixon K, Morris SA, Liput DJ, Kelso ML (2010) Roles of neural stem cells and adult neurogenesis in adolescent alcohol use disorders. Alcohol 44(1):39–56. doi: 10.1016/j.alcohol.2009.11.001 PubMedPubMedCentralGoogle Scholar
  105. 105.
    Nonaka H (1983) Acidophilic crystalline inclusion body in the caudate nerve cells. Acta Pathol Jpn 33(5):855–861PubMedGoogle Scholar
  106. 106.
    Norman AL, Crocker N, Mattson SN, Riley EP (2009) Neuroimaging and fetal alcohol spectrum disorders. Dev Disabil Res Rev 15(3):209–217. doi: 10.1002/ddrr.72 PubMedPubMedCentralGoogle Scholar
  107. 107.
    Novak DJ, Victor M (1973) Affection of the vagus and sympathetic nerves in alcoholic polyneuropathy. Trans Am Neurol Assoc 98:63–67PubMedGoogle Scholar
  108. 108.
    Novak DJ, Victor M (1974) The vagus and sympathetic nerves in alcoholic polyneuropathy. Arch Neurol 30(4):273–284PubMedGoogle Scholar
  109. 109.
    Ogershok PR, Rahman A, Nestor S, Brick J (2002) Wernicke encephalopathy in nonalcoholic patients. Am J Med Sci 323(2):107–111PubMedGoogle Scholar
  110. 110.
    Oishi M, Mochizuki Y, Shikata E (1999) Corpus callosum atrophy and cerebral blood flow in chronic alcoholics. J Neurol Sci 162(1):51–55PubMedGoogle Scholar
  111. 111.
    Okeda R, Kitano M, Sawabe M, Yamada I, Yamada M (1986) Distribution of demyelinating lesions in pontine and extrapontine myelinolysis—three autopsy cases including one case devoid of central pontine myelinolysis. Acta Neuropathol 69(3–4):259–266PubMedGoogle Scholar
  112. 112.
    Oliveira FA, Galan DT, Ribeiro AM, Santos Cruz J (2007) Thiamine deficiency during pregnancy leads to cerebellar neuronal death in rat offspring: role of voltage-dependent K+ channels. Brain Res 1134(1):79–86. doi: 10.1016/j.brainres.2006.11.064 PubMedGoogle Scholar
  113. 113.
    Pasutharnchat N, Phanthumchinda K (2002) Marchiafava–Bignami disease: a case report. J Med Assoc Thailand = Chotmaihet Thangphaet 85(6):742–746Google Scholar
  114. 114.
    Pfefferbaum A, Lim KO, Desmond JE, Sullivan EV (1996) Thinning of the corpus callosum in older alcoholic men: a magnetic resonance imaging study. Alcohol Clin Exp Res 20(4):752–757PubMedGoogle Scholar
  115. 115.
    Pitel AL, Chanraud S, Sullivan EV, Pfefferbaum A (2010) Callosal microstructural abnormalities in Alzheimer’s disease and alcoholism: same phenotype, different mechanisms. Psychiatry Res 184(1):49–56. doi: 10.1016/j.pscychresns.2010.07.006 PubMedPubMedCentralGoogle Scholar
  116. 116.
    Pitel AL, Chetelat G, Le Berre AP, Desgranges B, Eustache F, Beaunieux H (2012) Macrostructural abnormalities in Korsakoff syndrome compared with uncomplicated alcoholism. Neurology 78(17):1330–1333. doi: 10.1212/WNL.0b013e318251834e PubMedGoogle Scholar
  117. 117.
    Pittella JE, de Castro LP (1990) Wernicke’s encephalopathy manifested as Korsakoff’s syndrome in a patient with promyelocytic leukemia. South Med J 83(5):570–573PubMedGoogle Scholar
  118. 118.
    Powers JM, McKeever PE (1976) Central pontine myelinolysis. An ultrastructural and elemental study. J Neurol Sci 29(1):65–81PubMedGoogle Scholar
  119. 119.
    Preedy VR, Adachi J, Ueno Y et al (2001) Alcoholic skeletal muscle myopathy: definitions, features, contribution of neuropathy, impact and diagnosis. Eur J Neurol: Off J Eur Fed Neurol Soc 8(6):677–687Google Scholar
  120. 120.
    Preedy VR, Crabb DW, Farres J, Emery PW (2007) Alcoholic myopathy and acetaldehyde. Nov Found Symp 285:158–177 (discussion 177–182, 198–159)Google Scholar
  121. 121.
    Preedy VR, Ohlendieck K, Adachi J et al (2003) The importance of alcohol-induced muscle disease. J Muscle Res Cell Motil 24(1):55–63PubMedGoogle Scholar
  122. 122.
    Ramirez T, Longato L, Dostalek M, Tong M, Wands JR, de la Monte SM (2013) Insulin resistance, ceramide accumulation and endoplasmic reticulum stress in experimental chronic alcohol-induced steatohepatitis. Alcohol 48(1):39–52. doi: 10.1093/alcalc/ags106 Google Scholar
  123. 123.
    Refaai MA, Nguyen PN, Cluette-Brown JE, Laposata M (2003) Ethyl arachidonate is the predominant fatty acid ethyl ester in the brains of alcohol-intoxicated subjects at autopsy. Lipids 38(3):269–273PubMedGoogle Scholar
  124. 124.
    Riethdorf L, Warzok R, Schwesinger G (1991) Alcoholic encephalopathies in autopsy material. Zentralblatt fur Pathologie 137(1):48–56PubMedGoogle Scholar
  125. 125.
    Riley EP, McGee CL (2005) Fetal alcohol spectrum disorders: an overview with emphasis on changes in brain and behavior. Exp Biol Med (Maywood) 230(6):357–365Google Scholar
  126. 126.
    Riley EP, McGee CL, Sowell ER (2004) Teratogenic effects of alcohol: a decade of brain imaging. Am J Medical Genet Part C Semin Med Genet 127C(1):35–41. doi: 10.1002/ajmg.c.30014 Google Scholar
  127. 127.
    Roebuck TM, Mattson SN, Riley EP (1998) A review of the neuroanatomical findings in children with fetal alcohol syndrome or prenatal exposure to alcohol. Alcohol Clin Exp Res 22(2):339–344PubMedGoogle Scholar
  128. 128.
    Roh JK, Nam H, Lee MC (1998) A case of central pontine and extrapontine myelinolysis with early hypermetabolism on 18FDG-PET scan. J Korean Med Sci 13(1):99–102PubMedPubMedCentralGoogle Scholar
  129. 129.
    Rubin E (1979) Alcoholic myopathy in heart and skeletal muscle. New Engl J Med 301(1):28–33. doi: 10.1056/NEJM197907053010107 PubMedGoogle Scholar
  130. 130.
    Rubin E, Katz AM, Lieber CS, Stein EP, Puszkin S (1976) Muscle damage produced by chronic alcohol consumption. Am J Pathol 83(3):499–516PubMedGoogle Scholar
  131. 131.
    Sacanella E, Fernandez-Sola J, Cofan M et al (1995) Chronic alcoholic myopathy: diagnostic clues and relationship with other ethanol-related diseases. QJM: Month J Assoc Phys 88(11):811–817Google Scholar
  132. 132.
    Sage JI, Van Uitert RL, Lepore FE (1984) Alcoholic myelopathy without substantial liver disease. A syndrome of progressive dorsal and lateral column dysfunction. Arch Neurol 41(9):999–1001PubMedGoogle Scholar
  133. 133.
    Said G (1980) A clinicopathologic study of acrodystrophic neuropathies. Muscle Nerve 3(6):491–501. doi: 10.1002/mus.880030606 PubMedGoogle Scholar
  134. 134.
    Salas-Salvado J, Garcia-Lorda P, Cuatrecasas G et al (2000) Wernicke’s syndrome after bariatric surgery. Clin Nutr 19(5):371–373. doi: 10.1054/clnu2000.0138 PubMedGoogle Scholar
  135. 135.
    Santos-Garcia D, Arias-Rivas S, Dapena D, Arias M (2007) Past hepatitis B virus infection and demyelinating multiphasic disease: casual or causal relationship? Neurologia 22(8):542–546PubMedGoogle Scholar
  136. 136.
    Sarris M, Garrick TM, Sheedy D, Harper CG (2002) Banking for the future: an Australian experience in brain banking. Pathology 34(3):225–229. doi: 10.1080/00313020220131260 PubMedGoogle Scholar
  137. 137.
    Schulte T, Muller-Oehring EM, Rohlfing T, Pfefferbaum A, Sullivan EV (2010) White matter fiber degradation attenuates hemispheric asymmetry when integrating visuomotor information. J Neurosci: Off J Soc Neurosci 30(36):12168–12178. doi: 10.1523/JNEUROSCI.2160-10.2010 Google Scholar
  138. 138.
    Sechi G, Serra A (2007) Wernicke’s encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol 6(5):442–455. doi: 10.1016/S1474-4422(07)70104-7 PubMedGoogle Scholar
  139. 139.
    Serdaru M, Hausser-Hauw C, Laplane D et al (1988) The clinical spectrum of alcoholic pellagra encephalopathy. A retrospective analysis of 22 cases studied pathologically. Brain. J Neurol 111(Pt 4):829–842Google Scholar
  140. 140.
    Sheedy D, Say M, Stevens J, Harper CG, Kril JJ (2012) Influence of liver pathology on markers of postmortem brain tissue quality. Alcohol Clin Exp Res 36(1):55–60. doi: 10.1111/j.1530-0277.2011.01580.x PubMedGoogle Scholar
  141. 141.
    Shiota JY, Nakano I, Kawamura M, Hirayama K (1996) An autopsy case of Marchiafava–Bignami disease with peculiar chronological CT changes in the corpus callosum: neuroradiopathological correlations. J Neurol Sci 136(1–2):90–93PubMedGoogle Scholar
  142. 142.
    Shormanov SV, Shormanova NS (2005) Histomorphometric characteristic of human brain in acute alcoholic intoxication. Sud Med Ekspert 48(2):13–16PubMedGoogle Scholar
  143. 143.
    Skuja S, Groma V, Smane L (2012) Alcoholism and cellular vulnerability in different brain regions. Ultrastruct Pathol 36(1):40–47. doi: 10(3109/01913123)2011629770 PubMedGoogle Scholar
  144. 144.
    Song SK, Rubin E (1972) Ethanol produces muscle damage in human volunteers. Science 175(4019):327–328PubMedGoogle Scholar
  145. 145.
    Spencer DC, Forno LS (2000) February 2000: Dementia with motor dysfunction in a patient with liver disease. Brain Pathol 10(2):315–316 (p 319)PubMedGoogle Scholar
  146. 146.
    Sripathirathan K, Brown J 3rd, Neafsey EJ, Collins MA (2009) Linking binge alcohol-induced neurodamage to brain edema and potential aquaporin-4 upregulation: evidence in rat organotypic brain slice cultures and in vivo. J Neurotrauma 26(2):261–273. doi: 10.1089/neu2008.0682 PubMedGoogle Scholar
  147. 147.
    Strohle A, Wolters M, Hahn A (2012) Alcohol intake—a two-edged sword. Part 1: metabolism and pathogenic effects of alcohol. Medizinische Monatsschrift fur Pharmazeuten 35(8):281–292 (quiz 293–284)PubMedGoogle Scholar
  148. 148.
    Sullivan EV, Pfefferbaum A (2009) Neuroimaging of the Wernicke–Korsakoff syndrome. Alcohol 44(2):155–165. doi: 10.1093/alcalc/agn103 Google Scholar
  149. 149.
    Sunnasy D, Cairns SR, Martin F, Slavin G, Peters TJ (1983) Chronic alcoholic skeletal muscle myopathy: a clinical, histological and biochemical assessment of muscle lipid. J Clin Pathol 36(7):778–784PubMedGoogle Scholar
  150. 150.
    Suzuki Y, Oishi M, Ogawa K, Mizutani T (2010) Atrophy of the parahippocampal gyrus and regional cerebral blood flow in the limbic system in chronic alcoholic patients. Alcohol 44(5):439–445. doi: 10.1016/j.alcohol.2010.05.003 PubMedGoogle Scholar
  151. 151.
    Szabo G, Petrasek J, Bala S (2012) Innate immunity and alcoholic liver disease. Dig Dis 30(Suppl 1):55–60. doi: 10.1159/000341126 PubMedGoogle Scholar
  152. 152.
    Takefuji S, Murase T, Sugimura Y et al (2007) Role of microglia in the pathogenesis of osmotic-induced demyelination. Exp Neurol 204(1):88–94. doi: 10.1016/j.expneurol.2006.09.025 PubMedGoogle Scholar
  153. 153.
    Thomson AD, Guerrini I, Marshall EJ (2012) The evolution and treatment of Korsakoff’s syndrome: out of sight, out of mind? Neuropsychol Rev 22(2):81–92. doi: 10.1007/s11065-012-9196-z PubMedPubMedCentralGoogle Scholar
  154. 154.
    Tiwari V, Chopra K (2013) Resveratrol abrogates alcohol-induced cognitive deficits by attenuating oxidative-nitrosative stress and inflammatory cascade in the adult rat brain. Neurochem Int 62(6):861–869. doi: 10.1016/j.neuint.2013.02.012 PubMedGoogle Scholar
  155. 155.
    Todd KG, Hazell AS, Butterworth RF (1999) Alcohol-thiamine interactions: an update on the pathogenesis of Wernicke encephalopathy. Addict Biol 4(3):261–272. doi: 10.1080/13556219971470 PubMedGoogle Scholar
  156. 156.
    Torvik A (1991) Wernicke’s encephalopathy—prevalence and clinical spectrum. Alcohol Suppl1:381–384Google Scholar
  157. 157.
    Tredici G, Minazzi M (1975) Alcoholic neuropathy. An electron-microscopic study. J Neurol Sci 25(3):333–346PubMedGoogle Scholar
  158. 158.
    Underwood MD, Mann JJ, Arango V (2007) Morphometry of dorsal raphe nucleus serotonergic neurons in alcoholism. Alcohol Clin Exp Res 31(5):837–845. doi: 10.1111/j.1530-0277.2007.00365.x PubMedGoogle Scholar
  159. 159.
    Urbano-Marquez A, Estruch R, Fernandez-Sola J, Nicolas JM, Pare JC, Rubin E (1995) The greater risk of alcoholic cardiomyopathy and myopathy in women compared with men. JAMA J Am Med Assoc 274(2):149–154Google Scholar
  160. 160.
    Urbano-Marquez A, Estruch R, Navarro-Lopez F, Grau JM, Mont L, Rubin E (1989) The effects of alcoholism on skeletal and cardiac muscle. New Engl J Med 320(7):409–415. doi: 10.1056/NEJM198902163200701 PubMedGoogle Scholar
  161. 161.
    Van Thiel DH, Gavaler JS, Tarter R, Schade RR, Stone BG (1985) Hepatic encephalopathy and the neural regulation of hypothalamic pituitary function. Semin Liver Dis 5(1):70–83. doi: 10.1055/s-2008-1041759 PubMedGoogle Scholar
  162. 162.
    Vetreno RP, Hall JM, Savage LM (2011) Alcohol-related amnesia and dementia: animal models have revealed the contributions of different etiological factors on neuropathology, neurochemical dysfunction and cognitive impairment. Neurobiol Learn Mem 96(4):596–608. doi: 10.1016/j.nlm.2011.01.003 PubMedPubMedCentralGoogle Scholar
  163. 163.
    Victor M (1994) Alcoholic dementia. Can J Neurol Sci Le J Can des Sci Neurol 21(2):88–99Google Scholar
  164. 164.
    Victor M, Adams RD, Cole M (1965) The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration. Medicine 44(5):345–396PubMedGoogle Scholar
  165. 165.
    Wozniak JR, Muetzel RL (2011) What does diffusion tensor imaging reveal about the brain and cognition in fetal alcohol spectrum disorders? Neuropsychol Rev 21(2):133–147. doi: 10.1007/s11065-011-9162-1 PubMedGoogle Scholar
  166. 166.
    Yengue P, Adler M, Bouhdid H, Mavroudakis N, Gelin M, Bourgeois N (2001) Hepatic myelopathy after splenorenal shunting: report of one case and review of the literature. Acta Gastro-enterol Belgica 64(2):231–233Google Scholar
  167. 167.
    Yokota O, Tsuchiya K, Terada S et al (2006) Frequency and clinicopathological characteristics of alcoholic cerebellar degeneration in Japan: a cross-sectional study of 1,509 postmortems. Acta Neuropathol 112(1):43–51. doi: 10.1007/s00401-006-0059-7 PubMedGoogle Scholar
  168. 168.
    Young C, Roth KA, Klocke BJ et al (2005) Role of caspase-3 in ethanol-induced developmental neurodegeneration. Neurobiol Dis 20(2):608–614. doi: 10.1016/j.nbd.2005.04.014 PubMedGoogle Scholar
  169. 169.
    Zahr NM, Kaufman KL, Harper CG (2011) Clinical and pathological features of alcohol-related brain damage. Nat Rev Neurol 7(5):284–294. doi: 10.1038/nrneurol.2011.42 PubMedGoogle Scholar
  170. 170.
    Zaki AE, Wardle EN, Canalese J, Ede RJ, Williams R (1983) Potential toxins of acute liver failure and their effects on blood-brain barrier permeability. Experientia 39(9):988–991PubMedGoogle Scholar
  171. 171.
    Zara G, Codemo V, Palmieri A et al (2012) Neurological complications in hyperemesis gravidarum. Neurol Sci: Off J Italian Neurol Soc Italian Soc Clin Neurophysiol 33(1):133–135. doi: 10.1007/s10072-011-0660-y Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Departments of Pathology (Neuropathology), Neurology, and MedicineRhode Island Hospital and the Warren Alpert Medical School of Brown UniversityProvidenceUSA
  2. 2.Disciplines of Medicine and PathologySydney Medical School, The University of SydneySydneyAustralia

Personalised recommendations